Caspase-8 deficiency: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== Caspase-8 Deficiency == | |||
[[File:Autosomal_recessive_-_en.svg|thumb|right|Diagram illustrating autosomal recessive inheritance.]] | |||
'''Caspase-8 deficiency''' is a rare genetic disorder characterized by a deficiency in the enzyme caspase-8, which plays a crucial role in the process of [[apoptosis]] and the regulation of the [[immune system]]. This condition is inherited in an [[autosomal recessive]] pattern, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected by the disorder. | |||
== | == Pathophysiology == | ||
Caspase-8 is a member of the [[caspase]] family of enzymes, which are essential for the execution of apoptosis, a form of programmed cell death. In addition to its role in apoptosis, caspase-8 is involved in the activation of [[NF-kB]] and the regulation of [[cytokine]] production, which are critical for immune responses. | |||
In individuals with caspase-8 deficiency, the lack of functional caspase-8 disrupts these processes, leading to impaired apoptosis and dysregulation of the immune system. This can result in increased susceptibility to infections, autoimmune disorders, and lymphoproliferative diseases. | |||
[[ | == Clinical Features == | ||
[[ | |||
[[ | Patients with caspase-8 deficiency may present with a variety of clinical features, including: | ||
* Recurrent infections due to impaired immune function. | |||
* Autoimmune manifestations, such as [[autoimmune hemolytic anemia]] or [[systemic lupus erythematosus]]. | |||
* Lymphoproliferative disorders, which may include [[lymphadenopathy]] and [[splenomegaly]]. | |||
== Diagnosis == | |||
The diagnosis of caspase-8 deficiency is typically made through genetic testing, which can identify mutations in the gene encoding caspase-8. Laboratory tests may also reveal abnormalities in immune function, such as reduced [[lymphocyte]] apoptosis and altered cytokine production. | |||
== Treatment == | |||
There is currently no cure for caspase-8 deficiency, and treatment is primarily supportive. Management strategies may include: | |||
* Prophylactic antibiotics to prevent infections. | |||
* Immunosuppressive therapy to control autoimmune symptoms. | |||
* Hematopoietic stem cell transplantation in severe cases. | |||
== Related Pages == | |||
* [[Apoptosis]] | * [[Apoptosis]] | ||
* [[ | * [[Caspase]] | ||
* [[ | * [[Autosomal recessive]] | ||
* [[ | * [[Immune system]] | ||
{{Genetic disorders}} | |||
[[Category:Genetic disorders]] | |||
[[Category:Immunology]] | |||
Revision as of 16:30, 16 February 2025
Caspase-8 Deficiency

Caspase-8 deficiency is a rare genetic disorder characterized by a deficiency in the enzyme caspase-8, which plays a crucial role in the process of apoptosis and the regulation of the immune system. This condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected by the disorder.
Pathophysiology
Caspase-8 is a member of the caspase family of enzymes, which are essential for the execution of apoptosis, a form of programmed cell death. In addition to its role in apoptosis, caspase-8 is involved in the activation of NF-kB and the regulation of cytokine production, which are critical for immune responses.
In individuals with caspase-8 deficiency, the lack of functional caspase-8 disrupts these processes, leading to impaired apoptosis and dysregulation of the immune system. This can result in increased susceptibility to infections, autoimmune disorders, and lymphoproliferative diseases.
Clinical Features
Patients with caspase-8 deficiency may present with a variety of clinical features, including:
- Recurrent infections due to impaired immune function.
- Autoimmune manifestations, such as autoimmune hemolytic anemia or systemic lupus erythematosus.
- Lymphoproliferative disorders, which may include lymphadenopathy and splenomegaly.
Diagnosis
The diagnosis of caspase-8 deficiency is typically made through genetic testing, which can identify mutations in the gene encoding caspase-8. Laboratory tests may also reveal abnormalities in immune function, such as reduced lymphocyte apoptosis and altered cytokine production.
Treatment
There is currently no cure for caspase-8 deficiency, and treatment is primarily supportive. Management strategies may include:
- Prophylactic antibiotics to prevent infections.
- Immunosuppressive therapy to control autoimmune symptoms.
- Hematopoietic stem cell transplantation in severe cases.
Related Pages
| Genetic disorders relating to deficiencies of transcription factor or coregulators | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|